Endotoxin produces a depressive-like episode in rats

Brain Research

Volumn 711, Issue 1-2, 1996, Pages 163-174

  Yirmiya, Raz ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Anorexia; Body weight; Depression; Imipramine; Lipopolysaccharide; Open field test; Saccharin preference; Sexual behavior; Social exploration; Tricyclic antidepressant

Indexed keywords

ANTIDEPRESSANT AGENT; ENDOTOXIN; IMIPRAMINE; LIPOPOLYSACCHARIDE; SACCHARIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANOREXIA; ARTICLE; CONTROLLED STUDY; DEPRESSION; FOOD INTAKE; IMMUNE SYSTEM; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEXUAL BEHAVIOR; SOCIAL BEHAVIOR;

EID: 0029962322     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(95)01415-2     Document Type: Article

References (72)

1. Abbey, S.E. and Garfinkel, P.E., Chronic fatigue syndrome and depression: cause, effect, or covariate, Rev. Infect. Dis., 13 (1991) S73-83.
2. Bagatell, C.J., Heiman, J.R., Rivier, J.E. and Bremner, W.J., Effects of endogenous testosterone and estradiol on sexual behavior in normal young men, J. Clin. Endocrinol. Metabol., 78 (1994) 711-716.
3. Barden, N., Reul, J.M.H.M. and Holsboer, F., Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system? Trends Neurosci., 18 (1995) 6-11.
4. Bluthe, R.M., Dantzer, R. and Kelley, K.W., Effects of interleukin 1 receptor on the behavioral effects of lipopolysaccharide in rats, Brain Res., 573 (1992) 318-320.
5. Bode, L., Zimmerman, W., Ferszt, R., Steinbach, F. and Ludwig, H., Borna disease virus genome transcribed and expressed in psychiatric patients, Nature Med., 1 (1995) 232-236
6. Brady, L.S., Whitfield, H.J., Fox, R.J., Gold, P.W. and Herkenham, M., Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain, J. Clin. Invest., 87 (1991) 831-837.
7. Brown, G.R., Rundell, J.R., McManis, S.E., Kendall, S.N., Zachary, R. and Temoshok, L., Prevalence of psychiatric disorders in early stages of HIV, Psychosom. Med., 54 (1992) 588-601.
8. Burnet, P.W.J., Michelson, D., Smith, M.A., Gold, P.W. and Sternberg, E.M., The effect of chronic imipramine administration on the densities of 5-HT1A and 5-HT2 receptors and the abundances of 5-HT receptor and transporter mRNA in the cortex, hippocampus and dorsal raphe of three strains of rat, Brain Res., 638 (1994) 311-324.
9. Calkins, J.H., Sigel, M.M., Nankin, H.R. and Lin, T., Interleukin-1 inhibits Leydig cell steroidogenesis in primary culture, Endocrinology, 123 (1988) 1605-1610.
10. Cannon, J.G. and Dinarello, C.A., Increased plasma interleukin-1 activity in woman after ovulation, Science, 227 (1985) 1247-1249.
11. Christeff, N., Auclair, M.C., Benassayag, C., Carli, A. and Nunez, E.A., Endotoxin-induced changes in sex steroid hormone levels in male rats, J. Steroid Biochem., 26 (1987) 67-71.
12. Cox, S.M., King, M.R., Casey, M.L. and Macdonald, P.C., Interleukin-1β, -1α, and -6 and prostaglandins in vaginal cervical fluids of pregnant women before and during labor, J. Clin. Endocrinol. Metabol., 77 (1993) 805-815.
13. Dinarello, C.A. and Wolff, S.M., The role of interleukin-1 in disease, New Engl. J. Med., 328 (1993) 106-113.
14. DSM-IV, Diagnostic and Statistical Manual of Mental Disorders, 4th edn., American Psychiatric Association, Washington, DC, 1994.
15. Dunn, A.J., Infection as a stressor: a cytokine-mediated activation of the hypothalamo-pituitary-adrenal axis? Ciba Foundation Symposium, 172 (1993) 226-242.
16. Dunn, A.J., Chapman, Y. and Antoon, M., Endotoxin-induced behavioral changes of mice in the multicompartment chamber are distinct from those of interleukin-1, Neurosci. Res. Commun., 10 (1992) 63-69.
17. Dunn, A.J. and Vickers, S.L., Neurochemical and neuroendocrine responses to Newcastle disease virus administration in mice, Brain Res., 645 (1994) 103-112.
18. Dunn, A.J. and Welch, J., Stress-and endotoxin-induced increases in brain tryptophan and serotonin metabolism depend on sympathetic nervous system activity, J. Neurochem., 57 (1991) 1615-1622.
19. Fent, K. and Zbinden, G., Toxicity of interferon and interleukin, Trends Pharmacol. Sci., 8 (1987) 100-105.
20. Foley, W.F., Traugott, U., LaRocca, N.G., Smith, C.R., Perlman, K.R., Caurso, L.S. and Scheinberg, L.C., A prospective study of depression and immune dysregulation in multiple sclerosis, Arch. Neurol., 49 (1992) 238-244.
21. Gao, B. and Cutler, M.G., Effects of acute and chronic imipramine administration of the antidepressants, imipramine, phenelzine and mianserin, on the social behavior of mice, Neuropharmacology, 33 (1994) 813-824.
22. Greenwood, R., Residual mental disorders after herpesvirus infections. In: E. Kurstak, Z.J. Lipowski and P.V. Morozov (Eds.), Viruses, Immunity and Mental Disorders, Plenum, New York, 1987, pp. 65-80.
23. Grossman, C.J., Interactions between the gonadal steroids and the immune system, Science, 227 (1985) 257-261.
24. Hendler, N., Infectious mononucleosis and psychiatric disorders. In: E. Kurstak, Z.J. Lipowski and P.V. Morozov (Eds.), Viruses, Immunity and Mental Disorders, Plenum, New York, 1987, pp. 81-94.
25. Herbert, T.B. and Cohen, S., Depression and immunity: A meta-analytic review, Psychol. Bull., 3 (1993) 472-486.
26. Hoffman, S.A., Schucard, D.M., Hardbeck, R.J. and Huffman, J.J., Chronic immune complex disease: behavioral and immunological correlates, Neuropathol. Exp. Neurol., 37 (1978) 426-436.
27. Holsboer, F., Neuroendocrinology of mood disorders. In: F.E. Bloom and D.J. Kupfer (Eds.), Psychopharmacology: The Fourth Generation of Progress, Raven Press, New York, 1995, pp. 957-969.
28. Holsboer, F., Liebel, R. and Hofschuster, E., Repeated dexamethasone test during depressive illness: normalization of test result compared with clinical improvement, J. Affect. Disord., 4 (1982) 93-101.
29. Hotchin, J. and Seegal, R., Alterations in behavior resulting from persistent lymphocytic choriomeningitis virus infection, Birth Defects: Original Article Series, 14 (1983) 171-178.
30. Katz, R.J., Animal model of depression: Pharmacological sensitivity of a hedonic deficit, Pharmacol. Biochem. Behav., 16 (1982) 965-968.
31. Kent, S., Bluthe, R.M., Kelley, K.W. and Dantzer, R., Sickness behavior as a new target for drug development, Trends Pharmacol. Sci., 13 (1992) 24-28.
32. Knussmann, R., Christiansen, K. and Couwenbergs, C., Relations between sex hormone levels and sexual behavior in men, Arch. Sex. Behav., 15 (1986) 429-445.
33. Komaroff, A.L. and Buchwald, D., Symptoms and signs of chronic fatigue syndrome, Rev. Infect. Dis., 13 (1991) S8-11.
34. Koob, G.F., Anhedonia as an animal model of depression. In G.F. Koob, C.L. Ehlers and D.J. Kupfer (Eds.), Animal Models of Depression, Birkhauser, Boston, 1990, pp. 163-183.
35. Krueger, J.M., Obal, F., Opp, M., Toth, L., Johannsen, L. and Cady, A.B., Somnogenic cytokines and models concerning their effects on sleep, Yale J. Biol. Med., 63 (1990) 157-172.
36. Logue, A.W., Taste aversion and the generality of the laws of learning, Psychol. Bull., 86 (1979) 276-296.
37. Maes, M. and Meltzer, H.Y., The serotonin hypothesis of major depression. In F.E. Bloom and D.J. Kupfer (Eds.), Psychopharmacology: The Fourth Generation of Progress, Raven Press, New York, 1995, pp. 933-944.
38. Maes, M., Scharpe, S., Meltzer, H.Y., Bosmans, E., Suy, E., Calabrese, J. and Cosyns, P., Relationships between interleukin-6 activity, acute phase proteins and HPA-axis function in severe depression, Psychiat. Res., 49 (1993) 11-27.
39. Maes, M., Smith, R. and Scharpe, S., The monocyte T-lymphocyte hypothesis of major depression, Psychoneuroendocrinology, 20 (1995) 111-116.
40. Marshal, P.S., Allergy and depression: a neurochemical threshold model of the relation between the illnesses, Psychol. Bull., 113 (1993) 23-43.
41. Martich, G.D., Boujoukos, A.J. and Suffredini, A.F., Response of man to endotoxin, Immunobiology, 187 (1993) 403-416.
42. Masana, M.I., Heyes, M.P. and Mefford, I.N., Indomethacin prevents increased catecholamine turnover in rat brain following systemic endotoxin challenge, Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 14 (1990) 609-621.
43. Mathew, R.J. and Weinman, M.L., Sexual dysfunctions in depression. Arch. Sex Behav., 11 (1982) 323-328.
44. McDonald, E.M., Mann, A.H. and Thomas, H.C., Interferons as mediators of psychiatric morbidity: an investigation in a trial of recombinant α-interferon in hepatitis-B carriers, Lancet, 2 (1987) 1175-1179.
45. McFarland, D.J. and Hotchin, J., Behavioral sequelae to early postnatal cytomegalovirus infection in mice, Physiol. Behav., 12 (1984) 45-47.
46. McFarland, D.J., Sikora, E. and Hotchin, J., Age at infection as a determinant of the behavioral effects of herpes encephalitis in mice, Physiol. Behav., 9 (1981) 87-89.
47. Meijer, A., Zakay-Rones, Z. and Morag, A., Post-influenzal psychiatric disorder in adolescents, Acta Psychiatr. Scand., 78 (1988) 176-181.
48. Minden, S.L. and Schiffer, R.B., Affective disorders in multiple sclerosis: review and recommendations for clinical research, Arch. Neurol., 47 (1990) 98-104.
49. Montgomery, S.A., Antidepressants in long-term treatment, Ann. Rev. Med., 45 (1994) 447-457.
50. Niiranen, A., Laaksonen, R., Iivanainen, M., Mattson, K., Fakkila, M. and Cantell, K., Behavioral assessment of patients treated with alpha-interferon, Acta Psychiat. Scand., 78 (1988) 622-626.
51. O'Reilly, B., Vander, A.J. and Kluger, M.J., Effects of chronic infusion of lipopolysaccharide on food intake and body temperature of the rat, Physiol. Behav., 42 (1988) 287-291.
52. Papp, M., Willner, P. and Muscat, R., An animal model of anhedonia: attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress, Psychopharmacology, 104 (1991) 255-259.
53. Parker, J., Smarr, K., Anderson, S., Hewett, J., Walker, S., Bridges, A. and Caldwell, W., Relationship of changes in helplessness and depression to disease activity in rheumatoid arthritis, J. Rheumatol., 19 (1992) 1901-1905.
54. Parry, B.L., Mood disorders linked to the reproductive cycle in women. In F.E. Bloom and D.J. Kupfer (Eds.), Psychopharmacology: The fourth Generation of Progress, Raven Press, New York, 1995, pp. 1029-1042.
55. Patarca, R., Klimas, N.G., Lugtendorf, S., Antoni, M. and Fletcher, MA., Dysregulated expression of tumor necrosis factor in chronic fatigue syndrome: interrelations with cellular sources and patterns of soluble immune mediator expression, Clin. Infect. Dis., 18 (1994) S147-53.
56. Revusky, S.H. and Bedarf, E.W., Association of illness with prior ingestion of novel foods, Science, 155 (1967) 219-220.
57. Rodin, G. and Voshart, K., Depression in the medically ill: an overview, Am. J. Psychiatry, 143 (1986) 696-705.
58. Schatzberg, A. and Schildkraut, J.J., Recent studies on norepinephrine systems in mood disorders. In F.E. Bloom and D.J. Kupfer (Eds.), Psychopharmacology: The Fourth Generation of Progress, Raven Press, New York, 1995, pp. 911-920.
59. Schwartz, J.A., Speed, N.M., Brunberg, J.A., Brewe, T.L., Brown, M. and Greden, J.F., Depression in stroke rehabilitation, Biol. Psychiatry, 33 (1993) 694-699.
60. Schobitz, B., De Kloet, E.R. and Holsboer, F., Gene expression and function of interleukin 1, interleukin 6 and tumor necrosis factor in the brain, Prog. Neurobiol., 44 (1994) 397-432.
61. Solinsky, Z.S., Hardy, C.A., Burright, R.G. and Domonick, P.J., The progression of behavioral and pathological effects of the parasite Toxocara canis in the mouse, Physiol. Behav., 35 (1985) 33-42.
62. Sommer, N., Loschmann, P.A., Northoff, G.H., Weller, M., Steinbrecher, A., Steinbach, J.P., Lichtenfels, R., Meyermann, R., Riethmuller, A., Fontana, A., Dichgans, J. and Martin, R., The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis, Nature Med., 1 (1995) 244-248.
63. Spratt, D.I., Cox, P., Orav, J., Moloney, J. and Bigos, T., Reproductive axis suppression in acute illness is related to disease severity, J. Clin. Endocrinol. Metabol., 76 (1993) 1548-1554.
64. Spriggs, D.R., Sherman, M.L., Michie, H., Arthur, K.A., Imamura, K., Wilmore, D., Frei, E. and Kufe, D.W., Recombinant human tumor necrosis factor administration as a 24-h intravenous infusion. A phase I and pharmacologic study, J. Natl. Cancer Inst., 80 (1988) 1039-1044.
65. Suzuki, T., Funada, M., Sugano, Y., Misawa, M., Okutomi, T., Soma, G.I. and Mizuno, D., Effects of a lipopolysaccharide from pantoea agglomerans on the cocaine-induced place preference, Life Sci., 54 (1994) PL75-PL80.
66. Tazi, A., Dantzer, R., Crestani, F. and Le Moal, M., Interleukin-1 induces conditioned taste aversion in rats: a possible explanation for its pituitary-adrenal stimulating activity, Brain Res., 473 (1988) 369-371.
67. Willner, P., Towell, A., Sampson, D., Sophokleous, S. and Muscat, R., Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant, Psychopharmacology, 93 (1987) 358-364.
68. Yehuda, R. and Nemeroff, C.B., Neuropeptide alterations in affective and anxiety disorders. In J.A. den Boer and J.M. Ad Sitsen (Eds.), Handbook of Depression and Anxiety, Marcel Dekker, New York, 1994, pp. 543-571.
69. Yirmiya, R., Avitsur, R., Donchin, O. and Cohen, E., Interleukin-1 inhibits sexual behavior in female but not in male rats, Brain Behav. Immun., 9 (1995) 220-233.
70. Yirmiya, R., Holder, M.D. and Garcia, J., Conditioned taste aversion in vasopressin-deficient rats (Brattleboro strain), Physiol. Behav., 39 (1987) 489-493.
71. Yirmiya, R., Rosen, H., Donchin, O. and Ovadia, H., Behavioral effects of lipopolysaccharide in rats: involvement of endogenous opioids, Brain Res., 648 (1994) 80-86.
72. Zalcman, S., Green-Johnson, J.M., Murray, L., Nance, D.M., Dyck, D., Anisman, H. and Greenberg, A.H., Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6, Brain Res., 643 (1994) 40-49.